Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Six to buy
Halfords
(The Daily Telegraph) Demand for electric cars has “soared” in the pandemic and is expected to grow further as the UK’s 2030 ban on petrol cars moves closer. So consider Halfords, which has invested heavily in an “electrified future” for the automotive industry, purchasing technology to service electric cars and training staff, which could give it a “competitive advantage” over smaller garages. It’s also counting on rising demand for electric bikes and scooters. It has invested in its online presence and digital sales rose by 76% in the latest quarter. 315p
CentralNic
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Mail on Sunday) CentralNic provides companies with software that allows them to create an online presence via websites and email marketing. The group operates worldwide and shares recently jumped after boss Ben Crawford revealed a 121% surge in sales in 2020 as firms rushed to make it as easy as possible for customers stuck at home to buy online. Though some investors may be inclined to take profits, the company looks set to continue at its current pace. It should keep delivering as more companies realise the value of a strong online presence. 81p
Rotork
(Investors’ Chronicle) Covid-19 weighed on Rotork’s operating profit in 2020, sending it down by 6%. But the industrial-valve specialist says demand has “started to show signs of recovery”. The company relies heavily on the oil and gas sectors, and as things begin to open up it looks set to recover alongside the wider economy. Its net cash position currently stands at £178m, two-thirds higher than last year. The strong balance sheet should allow it to ride out the end of the pandemic. 372p
Dotdigital
(Shares Magazine) Dotdigital is “a true software-as-a-service (SaaS) rarity” and its shares look poised to reward investors “handsomely” in the years to come. Its platform provides digital-marketing firms with all the necessary tools to design, create and monitor campaigns. In the six months to December 2020 the company produced organic revenue growth of 22% to £28.2m, and earnings before interest, tax, depreciation and amortisation jumped by 13% to £10.5m. Dotdigital “has certainly been a Covid-19 winner”, but its success is likely to extend “far beyond lockdown”. 170p
Vertex Pharmaceuticals
(Barron’s) Vertex Pharmaceuticals’ shares climbed by over 800% from 2012 to 2020. But in mid-October the company cancelled its development of a “once-promising drug” after disappointing trial results. The stock tumbled by 25%, which presents “an opportunity for investors to get back in”. The firm remains “a powerhouse in cystic fibrosis treatment” and its pipeline beyond the disease is also “coming into focus”. It is trialling sickle-cell, kidney disorder and Type-1 diabetes treatments as well as experimental pain drugs, all of which present growth opportunities. $208.44
Rentokil
(Interactive Investor) Rentokil reported an increase in sales of over a third in 2020 as its specialist-cleaning and disinfection products thrived during the pandemic. The result was the resumption of its dividend as profits rose by 4% to £355m. Overall revenue increased by 5% to £2.8bn, although sales at its pest-control business rose by only 1% as hotels, restaurants, schools and offices closed. Nevertheless, things should improve as the economy opens up. Long-term momentum seems to be “in the company’s favour”. 467p
...and the rest
The Times
Oil firm Lamprell’s foray into the renewable-energy sector has yielded encouraging results. But the group will be in the red until at least 2022 and there is “no dividend in sight”. Avoid (78p).
Investors’ Chronicle
Power-converter specialist XP Power had a productive 2020, with profits jumping by nearly a third to £46m for the year as sales in semiconductor-equipment surged. The firm also expanded its manufacturing facility in Vietnam in 2019, which helped shield it from the impact of US tariffs on goods imported from China. Buy (5,400p). Precious metals miner Polymetal “kept things simple in 2020”, maintaining its cost level and letting profits “roll in” as gold prices rose. Buy (1,472p).
The Mail on Sunday
Shares in maps-software firm 1Spatial look set to increase as the company rolls out its growth strategy. The business has “a number of blue-chip customers” and its operations are expanding overseas too. The order book for forthcoming projects is “strong”. Buy (35p).
Shares magazine
Supermarket Income Reit’s 4.5% return in the past year “may not... quicken the pulses”, but its forward yield of 5.4% looks attractive. The portfolio leans heavily towards supermarkets that can fulfil online orders, which has proved a winning strategy during the pandemic. Buy (110p). France’s Eurofins is a leader in pharmaceutical and cosmetics-laboratory testing. Its full-year 2020 results exceeded market forecasts and it has raised its 2022 and 2023 projections. The current share pullback owing to the “flight from quality” is the ideal opportunity to invest before the stock makes “new highs on the raised targets”. Buy (€75.29).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Could investing in sugar protect you during a downturn?
Sugar has some defensive qualities during economic downturns, but is now the right time to invest in sugar?
By Dan McEvoy
-
Trump’s tariffs: how should the UK respond?
Every right-thinking person knows that free trade is a surer route to the wealth of nations than protectionism. So, what is Trump thinking?
By Stuart Watkins
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves